Showing results (51-60 of 139) with videos related to

Sort By:
Pageof 14
Open Forum Infectious Diseases|February 21, 2024
Guidance for the Interpretation of Long-Acting Cabotegravir and Rilpivirine Concentrations Based on Real-World Therapeutic Drug Monitoring Data and Documented FailuresPaul Thoueille, Matthias Cavassini, Monia Guidi, et al.
Clinical Pharmacokinetics|March 13, 2013
Prediction of drug-drug interactions between various antidepressants and efavirenz or boosted protease inhibitors using a physiologically based pharmacokinetic modelling approachMarco Siccardi, Catia Marzolini, Kay Seden, et al.
AIDS (London, England)|April 13, 2026
Assessing ChatGPT's capability in understanding and reporting antiretroviral therapy drug-drug interactions (ACCURATE-DDI)Erin A Ready, Corbin Patterson, Sara Gibbons, et al.
AIDS (London, England)|February 7, 2020
Aging does not impact drug--drug interaction magnitudes with antiretroviralsFelix Stader, Laurent Decosterd, Marcel Stoeckle, et al.
Clinical Pharmacology and Therapeutics|January 25, 2003
Population pharmacokinetics and effects of efavirenz in patients with human immunodeficiency virus infectionChantal Csajka, Catia Marzolini, Karin Fattinger, et al.
British Journal of Clinical Pharmacology|May 30, 2020
Effect of ageing on antiretroviral drug pharmacokinetics using clinical data combined with modelling and simulationFelix Stader, Perrine Courlet, Hannah Kinvig, et al.
The Journal of Antimicrobial Chemotherapy|August 5, 2020
Drug interactions: a review of the unseen danger of experimental COVID-19 therapiesDaryl Hodge, Fiona Marra, Catia Marzolini, et al.
Clinical Pharmacology and Therapeutics|August 11, 2020
Clinical Data Combined With Modeling and Simulation Indicate Unchanged Drug-Drug Interaction Magnitudes in the ElderlyFelix Stader, Perrine Courlet, Hannah Kinvig, et al.
British Journal of Clinical Pharmacology|November 23, 2023
Population pharmacokinetic analysis of doravirine in real-world people with HIVPaul Thoueille, Luc Delarive, Matthias Cavassini, et al.
European Journal of Clinical Pharmacology|January 20, 2005
Variations of CYP3A activity induced by antiretroviral treatment in HIV-1 infected patientsJacques Fellay, Catia Marzolini, Laurent Decosterd, et al.
Pageof 14